Whitehawk Therapeutics (WHWK) Equity Average (2011 - 2026)
Whitehawk Therapeutics (WHWK) reported Equity Average of $126.2 million for Q1 2026, down 7.92% year-over-year from $137.1 million in Q1 2025, and down 13.97% on a QoQ basis from $146.7 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 16 years of Equity Average data on file, last reported at $126.2 million in Q1 2026.
- Quarterly Equity Average fell 7.92% year-over-year to $126.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.2 million (down 7.92% YoY) and the FY2025 annual result came in at $94.4 million, up 19.73% from the prior year.
- Equity Average slipped to $126.2 million in Q1 2026 per WHWK's latest filing, from $146.7 million in the prior quarter.
- Across five years, Equity Average topped out at $196.9 million in Q2 2025 and bottomed at $60.7 million in Q4 2024.
- The 5-year median for Equity Average is $130.5 million (2022), against an average of $127.4 million.
- The widest annual swing landed in 2022, when Equity Average jumped 961.38%; it then plunged 45.68% in 2024.
- Tracing WHWK's Equity Average over 5 years: stood at $163.7 million in 2022, then plunged by 31.79% to $111.7 million in 2023, then sank by 45.68% to $60.7 million in 2024, then jumped by 141.85% to $146.7 million in 2025, then fell by 13.97% to $126.2 million in 2026.
- Per Business Quant, the three latest WHWK Equity Average figures stand at $126.2 million (Q1 2026), $146.7 million (Q4 2025), and $164.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 126.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.24 Mn |
| Dec 31, 2025 | 146.74 Mn |
| Sep 30, 2025 | 164.62 Mn |
| Jun 30, 2025 | 196.90 Mn |
| Mar 31, 2025 | 137.10 Mn |
| Dec 31, 2024 | 60.67 Mn |
| Sep 30, 2024 | 73.83 Mn |
| Jun 30, 2024 | 84.63 Mn |
| Mar 31, 2024 | 97.83 Mn |
| Dec 31, 2023 | 111.70 Mn |
| Sep 30, 2023 | 124.81 Mn |
| Jun 30, 2023 | 138.70 Mn |
| Mar 31, 2023 | 152.18 Mn |
| Dec 31, 2022 | 163.74 Mn |
| Sep 30, 2022 | 138.92 Mn |
| Jun 30, 2022 | 116.68 Mn |
| Mar 31, 2022 | 130.52 Mn |
| Dec 31, 2021 | 143.67 Mn |
| Sep 30, 2021 | 65.78 Mn |
| Jun 30, 2021 | -18.62 Mn |
| Mar 31, 2021 | -15.15 Mn |
| Dec 31, 2020 | -16.46 Mn |
| Sep 30, 2020 | -19.06 Mn |
| Jun 30, 2020 | -15.01 Mn |
| Mar 31, 2020 | -10.74 Mn |
| Dec 31, 2019 | 16.31 Mn |
| Sep 30, 2019 | 43.72 Mn |
| Jun 30, 2019 | 48.26 Mn |
| Mar 31, 2019 | 54.73 Mn |
| Dec 31, 2018 | 62.59 Mn |
| Sep 30, 2018 | 57.21 Mn |
| Jun 30, 2018 | 29.51 Mn |
| Mar 31, 2018 | 14.27 Mn |
| Dec 31, 2017 | 20.43 Mn |
| Sep 30, 2017 | 25.68 Mn |
| Jun 30, 2017 | 30.62 Mn |
| Mar 31, 2017 | -26.45 Mn |
| Dec 31, 2016 | -43.21 Mn |
| Sep 30, 2016 | -203,870.00 |
| Jun 30, 2016 | -196,660.00 |
| Mar 31, 2016 | -33.37 Mn |
| Dec 31, 2015 | -33.36 Mn |
| Sep 30, 2015 | -171,388.50 |
| Jun 30, 2015 | -164,492.00 |
| Mar 31, 2015 | -157,948.50 |
| Dec 31, 2014 | -149,214.50 |
| Sep 30, 2014 | -140,174.00 |
| Jun 30, 2014 | -133,484.00 |
| Mar 31, 2014 | -127,125.00 |
| Dec 31, 2013 | -119,367.00 |
| Sep 30, 2013 | -111,422.50 |
| Jun 30, 2013 | -104,978.50 |
| Mar 31, 2013 | -98,572.50 |
| Dec 31, 2012 | -90,710.00 |
| Sep 30, 2012 | -82,860.00 |
| Jun 30, 2012 | -76,689.50 |
| Mar 31, 2012 | -70,857.00 |
| Dec 31, 2011 | -63,709.00 |
| Sep 30, 2011 | -56,073.50 |